MedTrace Logo

Comparative Study Between Rezum Therapy in Small and Large Prostates

NCT06818383 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 178

Last updated 2025-02-12

No results posted yet for this study

Summary

The investigators aimed to compare the efficacy and safety of Rezūm therapy for the management of benign prostatic hyperplasia (BPH) in small and large prostates.

Conditions

  • Prostate Hyperplasia

Interventions

DEVICE

Rezum therapy

minimal invasive technique for treating BPH

Sponsors & Collaborators

  • khaled Abdelsattar Gad Ibrahim

    lead OTHER

Principal Investigators

  • Mohamed Samir Salem, MD

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2025-01-01
Completion
2025-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06818383 on ClinicalTrials.gov